N/A
N=2,589
Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates
Herpes Zoster Disease
Bottom Line
View on ClinicalTrials.gov: NCT01519570 ↗Enrolled (actual)
2,589
Serious AEs
0.0%
Results posted
Feb 2019
Primary outcome: Primary: Number of Participants Who Received the Herpes Zoster Vaccine — 500; 2089 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- An informational packet regarding shingles and the HZV was sent to patients identified by the EMR (Other)
- Age
- Adult, Older Adult · 60+ yrs
- Sex
- All
- Sponsor
- Ohio State University
- Primary completion
- Dec 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Received the Herpes Zoster Vaccine |
500; 2089 | — |
| SECONDARY Difference in Vaccination Rates Between Patients Who Recieved a Mailed Letter Versus a Secure Email |
— | — |
| SECONDARY Amount of Time Required by a Clinical Pharmacist to Manage This Workflow |
— | — |
Summary
Despite the significant benefits of herpes zoster vaccine (HZV), vaccination rates remain low. Electronic medical records (EMR) can serve as a practical strategy to better facilitate the application of preventative health care, such as increasing immunization rates. A new care model that can increase the herpes zoster vaccination rate, as well as other preventative health services, is warranted. The objective of this study is to investigate if the functions of an EMR, in combination with a pharmacist as part of the care team, can improve the herpes zoster vaccination rate.
Eligibility Criteria
Inclusion Criteria
- Greater than 60 years of age
Exclusion Criteria
- Documented herpes zoster vaccine in the EMR
Data sourced from ClinicalTrials.gov (NCT01519570). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.